DERMA PHARM A/S: Financial statements 2024
CVR: 89453119
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 106,271,000 and a net result of DKK 18,538,000 compared with DKK 9,574,416 the year before. That is an increase of 30.7% compared with the year before. Equity in the 2024 report amounted to DKK 59,642,000. The solvency ratio was 39.9%. The company had 122 employees in the financial year.
- Gross Profit
- DKK 106,271,000
- Profit/Loss
- DKK 18,538,000
- Equity
- DKK 59,642,000
- Total Assets
- DKK 149,534,000
- Employees
- 122
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 106.3 mio. | 18.5 mio. | 59.6 mio. | 122 |
| 2023 | - | 81.3 mio. | 9.6 mio. | 46.6 mio. | 117 |
| 2022 | - | 71.2 mio. | 4 mio. | 39.5 mio. | 121 |
| 2021 | - | 70.7 mio. | 7.2 mio. | 39.6 mio. | 115 |
| 2020 | - | 76.2 mio. | 12 mio. | 40.5 mio. | 108 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
DERMA PHARM A/S has published its annual report for 2023. Gross profit came to DKK 81,333,290, and the net result was DKK 9,574,416.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.